The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids

Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids
Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids
Obesity is believed to be associated with a dysregulated endocannabinoid system which may reflect enhanced inflammation. However, reports of this in human white adipose tissue (WAT) are limited and inconclusive. Marine long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFAs) have anti-inflammatory actions and therefore may improve obesity-associated adipose tissue inflammation. Therefore, fatty acid (FA) concentrations, endocannabinoid concentrations, and gene expression were assessed in subcutaneous WAT (scWAT) biopsies from healthy normal weight individuals (BMI 18.5–25 kg/m2) and individuals living with metabolically healthy obesity (BMI 30–40 kg/m2) prior to and following a 12-week intervention with 3 g fish oil/day (1.1 g eicosapentaenoic acid (EPA) + 0.8 g DHA) or 3 g corn oil/day (placebo). WAT from individuals living with metabolically healthy obesity had higher n-6 PUFAs and EPA, higher concentrations of two endocannabinoids (anandamide (AEA) and eicosapentaenoyl ethanolamide (EPEA)), higher expression of phospholipase A2 Group IID (PLA2G2D) and phospholipase A2 Group IVA (PLA2G4A), and lower expression of CNR1. In response to fish oil intervention, WAT EPA increased to a similar extent in both BMI groups, and WAT DHA increased by a greater extent in normal weight individuals. WAT EPEA and docosahexaenoyl ethanolamide (DHEA) increased in normal weight individuals only and WAT 2-arachidonyl glycerol (2-AG) decreased in individuals living with metabolically healthy obesity only. Altered WAT fatty acid, endocannabinoid, and gene expression profiles in metabolically healthy obesity at baseline may be linked. WAT incorporates n-3 PUFAs when their intake is increased which affects the endocannabinoid system; however, effects appear greater in normal weight individuals than in those living with metabolically healthy obesity.
0143-5221
185-200
Fisk, Helena
2483d346-75dd-41b3-a481-10f8bb39cd9f
Childs, Caroline
ea17ccc1-2eac-4f67-96c7-a0c4d9dfd9c5
Miles, Elizabeth
20332899-ecdb-4214-95bc-922dde36d416
Ayres, Robert
da3a1f2b-432f-46f8-857f-ceae18ce7b40
Noakes, Paul S.
4a78bc2c-3756-4af4-a7c6-7a7b9314f124
Paras Chavez, Carolina
f0170853-485a-4ef7-bc03-727884b13dbd
Kuda, Ondrej
cbc45f70-44cf-421a-be89-2d5213be9591
Kopecky, Jan
92b2a92a-9a55-48ea-a442-e79d1939b9e7
Antoun, Elie
01125a89-00e1-45ae-b7ef-aa79cfe052e8
Lillycrop, Karen
eeaaa78d-0c4d-4033-a178-60ce7345a2cc
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6
Fisk, Helena
2483d346-75dd-41b3-a481-10f8bb39cd9f
Childs, Caroline
ea17ccc1-2eac-4f67-96c7-a0c4d9dfd9c5
Miles, Elizabeth
20332899-ecdb-4214-95bc-922dde36d416
Ayres, Robert
da3a1f2b-432f-46f8-857f-ceae18ce7b40
Noakes, Paul S.
4a78bc2c-3756-4af4-a7c6-7a7b9314f124
Paras Chavez, Carolina
f0170853-485a-4ef7-bc03-727884b13dbd
Kuda, Ondrej
cbc45f70-44cf-421a-be89-2d5213be9591
Kopecky, Jan
92b2a92a-9a55-48ea-a442-e79d1939b9e7
Antoun, Elie
01125a89-00e1-45ae-b7ef-aa79cfe052e8
Lillycrop, Karen
eeaaa78d-0c4d-4033-a178-60ce7345a2cc
Calder, Philip
1797e54f-378e-4dcb-80a4-3e30018f07a6

Fisk, Helena, Childs, Caroline, Miles, Elizabeth, Ayres, Robert, Noakes, Paul S., Paras Chavez, Carolina, Kuda, Ondrej, Kopecky, Jan, Antoun, Elie, Lillycrop, Karen and Calder, Philip (2021) Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity and modulation by omega-3 polyunsaturated fatty acids. Clinical Science, 135 (1), 185-200, [CS20201060]. (doi:10.1042/CS20201060).

Record type: Article

Abstract

Obesity is believed to be associated with a dysregulated endocannabinoid system which may reflect enhanced inflammation. However, reports of this in human white adipose tissue (WAT) are limited and inconclusive. Marine long-chain omega-3 polyunsaturated fatty acids (LC n-3 PUFAs) have anti-inflammatory actions and therefore may improve obesity-associated adipose tissue inflammation. Therefore, fatty acid (FA) concentrations, endocannabinoid concentrations, and gene expression were assessed in subcutaneous WAT (scWAT) biopsies from healthy normal weight individuals (BMI 18.5–25 kg/m2) and individuals living with metabolically healthy obesity (BMI 30–40 kg/m2) prior to and following a 12-week intervention with 3 g fish oil/day (1.1 g eicosapentaenoic acid (EPA) + 0.8 g DHA) or 3 g corn oil/day (placebo). WAT from individuals living with metabolically healthy obesity had higher n-6 PUFAs and EPA, higher concentrations of two endocannabinoids (anandamide (AEA) and eicosapentaenoyl ethanolamide (EPEA)), higher expression of phospholipase A2 Group IID (PLA2G2D) and phospholipase A2 Group IVA (PLA2G4A), and lower expression of CNR1. In response to fish oil intervention, WAT EPA increased to a similar extent in both BMI groups, and WAT DHA increased by a greater extent in normal weight individuals. WAT EPEA and docosahexaenoyl ethanolamide (DHEA) increased in normal weight individuals only and WAT 2-arachidonyl glycerol (2-AG) decreased in individuals living with metabolically healthy obesity only. Altered WAT fatty acid, endocannabinoid, and gene expression profiles in metabolically healthy obesity at baseline may be linked. WAT incorporates n-3 PUFAs when their intake is increased which affects the endocannabinoid system; however, effects appear greater in normal weight individuals than in those living with metabolically healthy obesity.

Text
Dysregulation of endocannabinoid concentrations in human subcutaneous adipose tissue in obesity.. - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (286kB)
Text
Table 1 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (86kB)
Text
Supplementary Table 1 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (82kB)
Text
Supplementary Table 2 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (100kB)
Image
endocannabinoid system overview Figure 1 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (250kB)
Image
Fig 2 study flow in weeks - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (27kB)
Image
Figure 3 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (414kB)
Image
Figure 4 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (104kB)
Image
Figure 5 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (111kB)
Image
Figure 6 - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (317kB)
Image
Figure 7 V2 % change in % EPA DPA and DHA revised - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (482kB)
Image
New figure 8 % change in AEA 2AG EPEA DHEA - Accepted Manuscript
Available under License University of Southampton Accepted Manuscript Licence.
Download (492kB)

Show all 12 downloads.

More information

Accepted/In Press date: 4 January 2021
e-pub ahead of print date: 8 January 2021
Published date: 8 January 2021
Additional Information: Funding Information: This work was supported by the European Commission through its Seventh Framework Programme, BIOmarkers of Robustness of Metabolic Homeostasis for Nutrigenomics-derived Health CLAIMS Made on Food [grant number 244995]. Publisher Copyright: © 2021 Portland Press Ltd. All rights reserved.
Learn more about Institute for Life Sciences research Learn more about Medicine research Learn more about Institute for Life Sciences research

Identifiers

Local EPrints ID: 446258
URI: http://eprints.soton.ac.uk/id/eprint/446258
DOI: doi:10.1042/CS20201060
ISSN: 0143-5221
PURE UUID: 3b40d24d-c1a0-4c53-8e93-1f9ea0e5328b
ORCID for Helena Fisk: ORCID iD orcid.org/0000-0002-9534-3246
ORCID for Caroline Childs: ORCID iD orcid.org/0000-0001-6832-224X
ORCID for Elizabeth Miles: ORCID iD orcid.org/0000-0002-8643-0655
ORCID for Karen Lillycrop: ORCID iD orcid.org/0000-0001-7350-5489
ORCID for Philip Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 02 Feb 2021 17:30
Last modified: 06 Jun 2024 04:13

Export record

Altmetrics

Contributors

Author: Helena Fisk ORCID iD
Author: Caroline Childs ORCID iD
Author: Elizabeth Miles ORCID iD
Author: Robert Ayres
Author: Paul S. Noakes
Author: Carolina Paras Chavez
Author: Ondrej Kuda
Author: Jan Kopecky
Author: Elie Antoun
Author: Karen Lillycrop ORCID iD
Author: Philip Calder ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×